NASDAQ (USD): Elevai Labs, Inc. Common Stock (ELAB)
Last Price
0.135
Today's Change
+0.05 (58.82%)
Day's Change
0.126 - 0.18
Trading Volume
493,039,866
You are setting up a price and signal alert with 15 minutes delay. Click here to enjoy real-time price and signal alerts.
T4Q
31-Mar-2021
2020
2019
2018
2017
Revenue
238
1000
110
900
600
12
MQ Chat
Send individual or group chats with anyone on i3investor
MQ Trader
Earn MQ Points while trading with MQ Trader
MQ Affiliate
Earn side income from Affiliate Program
MQdemy
Online learning and teaching marketplace
1
CEO Morning Brief
US Imposes Duties on Solar Panels From Southeast Asia
2
Sheinbaum Sworn in as Mexico's First Female President, Vows 'it's Time for Women'
3
US Companies Add More Jobs Than Forecast, ADP Data Show
4
Bitcoin Totters in Poor Start to Token’s Best Month Historically
5
Apple Accused by US Labour Board of Imposing Illegal Workplace Rules
#
Stock
Score
BABA
Alibaba Group Holding Limited
PLTR
Palantir Technologies Inc.
875
MTC
MMTec, Inc.
500
GSIW
Garden Stage Limited Ordinary Shares
AGN
375
6
ORCL
Oracle Corporation
7
IRIS
275
8
FLR
Fluor Corporation
250
9
BX
Blackstone Inc.
10
HTGC
Hercules Capital, Inc.
Last
Change
Volume
ELAB
+0.05
NVDA
122.43
+3.58
237,060,870
PEGY
0.141
+0.026
166,772,476
KXIN
0.413
+0.071
152,507,582
MLGO
0.371
+0.061
150,220,234
SQQQ
7.75
+0.085
137,643,203
LMDX
0.016
-0.018
120,553,903
EVGO
6.30
+2.37
115,170,848
XPON
0.048
+0.001
94,435,278
762.00
-84.71
85,558,284
TPL
963.15
+33.14
81,272
FCNCA
1,860.36
+33.13
51,455
MKTX
272.32
+17.40
495,032
CEG
276.41
+11.03
3,278,993
MPC
175.13
+9.75
2,004,563
AXON
413.50
+8.99
433,055
VLO
144.60
+8.92
3,787,074
WTM
1,763.70
+8.69
3,142
FUTU
121.08
+8.23
18,140,655
BIO-B
334.85
+8.109
129
BRK-A
678,554.08
-6,445.875
1,338
MELI
1,629.32
-188.66
1,851,535
MSTR
1,309.00
-138.99
2,237,917
MKL
1,395.13
-102.30
318,280
MPWR
838.63
-96.05
902,546
NVR
9,636.76
-95.87
14,177
NOW
643.29
-87.83
5,025,012
MEDP
357.30
-79.88
1,004,401
SEB
3,064.61
-77.97
3,370
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....